Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
May 10, 2002	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950123-02-004899.pdf 0000950123-02-004899.xls
May 08, 2002	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0000950123-02-004815.pdf
Apr 26, 2002	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-02-004260.pdf
Apr 10, 2002	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000315066-02-001525.pdf
Mar 22, 2002	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000950123-02-002817.pdf 0000950123-02-002817.xls
Feb 14, 2002	SC 13G/A	An amendment to the SC 13G filing	View HTML 9999999997-02-010987.pdf
Feb 13, 2002	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-02-001454.pdf
Feb 12, 2002	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000902219-02-000997.pdf
Feb 07, 2002	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-02-001029.pdf
Feb 04, 2002	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001021408-02-001289.pdf

Data provided by Kaleidoscope.

Investors & Media